Physician profile
Casey Owen Mccraw
NPI 1336403260
$22,592.93
in general payments reported to CMS, 2019-2025
36 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,366 · 2020: $1,112 · 2021: $3,565 · 2022: $2,583 · 2023: $3,068 · 2024: $1,263 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,600 · Travel and Lodging: $1,241 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,600.31 |
| Travel and Lodging | $1,240.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $124.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $8,677.21 | 2019-2025 | Titan |
| Boston Scientific Corporation | $7,014.23 | 2019-2025 | General - Erectile Dysfunction, Moses, Ams 700 Cxr Rte Kit |
| Neotract INC. | $3,184.33 | 2019-2020 | |
| Astellas Pharma US INC | $634.33 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Sumitomo Pharma America, INC. | $399.93 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $361.56 | 2019-2023 | Xiaflex |
| Myriad Genetic Laboratories, INC. | $307.72 | 2022-2023 | Prolaris |
| Dendreon Pharmaceuticals LLC | $249.94 | 2019-2024 | Provenge |
| Medtronic, INC. | $177.11 | 2023-2025 | Interstim |
| Intuitive Surgical, INC. | $152.35 | 2019 | |
| Ferring Pharmaceuticals INC. | $145.68 | 2019-2020 | |
| Antares Pharma, INC. | $140.76 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Telix Pharmaceuticals | $138.51 | 2024-2025 | Illuccix |
| Janssen Biotech, INC. | $132.19 | 2019-2025 | Erleada |
| Teleflex LLC | $120.77 | 2022-2025 | Barrigel |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $110.18 | 2019-2022 | |
| Urogen Pharma, INC. | $88.51 | 2022-2025 | Jelmyto |
| Accord Healthcare, INC. | $51.54 | 2023-2024 | |
| Axonics, INC. | $45.45 | 2021-2024 | Bulkamid, Axonics |
| Alnylam Pharmaceuticals INC. | $43.35 | 2021 | |
| Pfizer INC. | $42.99 | 2019-2022 | |
| Abbvie INC. | $42.90 | 2023-2025 | |
| Endo USA, INC. | $40.68 | 2024-2025 | Xiaflex |
| Laborie Medical Technologies Corp. | $39.50 | 2025 | Optilume Bph Drug Coated Balloon Catheter, Optilume Urethral Drug Coated Balloon |
| Urovant Sciences INC | $30.68 | 2022 | |
| Myovant Sciences INC. | $28.45 | 2022 | |
| Photocure INC | $23.54 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.50 | 2025 | |
| Ethicon US, LLC | $21.68 | 2023 | Mega Soft |
| Immunitybio, INC. | $20.81 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.71 | 2020 | |
| Innovation Technologies INC | $20.27 | 2024 | Irrisept |
| Avadel Specialty Pharmaceuticals, LLC | $18.81 | 2019 | |
| Srs Medical Systems, INC. | $15.65 | 2019 | |
| Allergan, INC. | $14.16 | 2019 | |
| Cycle Pharmaceuticals INC | $13.95 | 2024 | Tiopronin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Mccraw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.